Chemistries & Methods: How We Achieve Breadth and Depth in Chemical Discovery

There are tens of thousands of unknown molecules circulating in human blood – thousands of which could represent robust biomarkers. Sapient uses our next-generation rapid liquid chromatography-mass spectrometry (rLC-MS) systems to provide nontargeted metabolomics services, rapidly measuring >15,000 small molecule biomarkers per biosample to identify key molecules of interest – including yet-unmapped chemistries. We then leverage a comprehensive follow-on technology pipeline to enable targeted profiling of the small molecule chemistries identified.

Download the infographic to see how Sapient leverages its high-powered methods to help biopharma sponsors identify and translate novel small molecule biomarkers at speed, scale, and with high specificity,